Eva Maria Brandtner

467 total citations
32 papers, 352 citations indexed

About

Eva Maria Brandtner is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Eva Maria Brandtner has authored 32 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Eva Maria Brandtner's work include Chronic Kidney Disease and Diabetes (5 papers), Lipid metabolism and disorders (5 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Eva Maria Brandtner is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Lipid metabolism and disorders (5 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Eva Maria Brandtner collaborates with scholars based in Austria, United States and Liechtenstein. Eva Maria Brandtner's co-authors include Andreas Leiherer, Axel Muendlein, Peter Fraunberger, Christoph H. Saely, Heinz Drexel, Kathrin Geiger, Heinz Drexel, Walter H. Günzburg, Alexander Vonbank and Brian Salmons and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Eva Maria Brandtner

29 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Maria Brandtner Austria 10 95 74 64 59 56 32 352
Guiping Li China 12 113 1.2× 57 0.8× 61 1.0× 48 0.8× 68 1.2× 55 475
Camilla Fanelli Brazil 13 109 1.1× 128 1.7× 41 0.6× 36 0.6× 41 0.7× 29 388
Victoria Bocanegra Argentina 11 175 1.8× 84 1.1× 36 0.6× 32 0.5× 33 0.6× 18 360
Jia‐Feng Chang Taiwan 16 161 1.7× 143 1.9× 54 0.8× 38 0.6× 55 1.0× 46 560
Mohamed M. S. Gaballa Egypt 11 90 0.9× 72 1.0× 28 0.4× 72 1.2× 58 1.0× 35 322
Francesca Leone Italy 14 103 1.1× 69 0.9× 34 0.5× 18 0.3× 71 1.3× 30 404
Xiaozhen Tan China 13 269 2.8× 51 0.7× 37 0.6× 64 1.1× 39 0.7× 27 504
Bing Du China 13 150 1.6× 49 0.7× 15 0.2× 72 1.2× 76 1.4× 29 504
Curtis Noordhof Canada 7 110 1.2× 54 0.7× 15 0.2× 55 0.9× 101 1.8× 11 366
Abdel R.A. Hamad United States 11 192 2.0× 125 1.7× 24 0.4× 36 0.6× 78 1.4× 13 560

Countries citing papers authored by Eva Maria Brandtner

Since Specialization
Citations

This map shows the geographic impact of Eva Maria Brandtner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Maria Brandtner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Maria Brandtner more than expected).

Fields of papers citing papers by Eva Maria Brandtner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Maria Brandtner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Maria Brandtner. The network helps show where Eva Maria Brandtner may publish in the future.

Co-authorship network of co-authors of Eva Maria Brandtner

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Maria Brandtner. A scholar is included among the top collaborators of Eva Maria Brandtner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Maria Brandtner. Eva Maria Brandtner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muendlein, Axel, Andreas Leiherer, Eva Maria Brandtner, et al.. (2025). Leucine-rich α-2 glycoprotein 1 is associated with increased mortality risk in patients with peripheral artery disease. Journal of Molecular Medicine. 103(11-12). 1475–1485.
2.
Muendlein, Axel, Kathrin Geiger, Christine Heinzle, et al.. (2023). Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients. Journal of Cancer Research and Clinical Oncology. 149(9). 6435–6444. 5 indexed citations
3.
Muendlein, Axel, Christine Heinzle, Eva Maria Brandtner, et al.. (2023). Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer. Oncology Research and Treatment. 46(4). 151–156. 5 indexed citations
4.
Muendlein, Axel, Christine Heinzle, Andreas Leiherer, et al.. (2023). Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure. Clinical Biochemistry. 121-122. 110675–110675. 3 indexed citations
5.
Geiger, Kathrin, Axel Muendlein, Andreas Leiherer, et al.. (2023). Myricetin attenuates hypoxia-induced inflammation in human adipocytes. Molecular Biology Reports. 50(12). 9833–9843.
6.
Muendlein, Axel, Christine Heinzle, Eva Maria Brandtner, et al.. (2023). Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients. Breast Cancer Research and Treatment. 201(3). 571–576. 2 indexed citations
7.
Muendlein, Axel, Eva Maria Brandtner, Andreas Leiherer, et al.. (2022). Evaluation of the association of serum glypican-4 with prevalent and future kidney function. Scientific Reports. 12(1). 10168–10168. 4 indexed citations
8.
Muendlein, Axel, Christine Heinzle, Andreas Leiherer, et al.. (2022). Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease. International Journal of Cardiology. 369. 54–59. 6 indexed citations
9.
Muendlein, Axel, Eva Maria Brandtner, Andreas Leiherer, et al.. (2022). Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography. Data in Brief. 42. 108142–108142. 2 indexed citations
10.
Muendlein, Axel, Eva Maria Brandtner, Andreas Leiherer, et al.. (2022). Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients. Atherosclerosis. 345. 33–38. 8 indexed citations
11.
Leiherer, Andreas, Hanno Ulmer, Axel Muendlein, et al.. (2021). Value of total cholesterol readings earlier versus later in life to predict cardiovascular risk. EBioMedicine. 67. 103371–103371. 6 indexed citations
12.
Günzburg, Walter H., et al.. (2020). Efficient protection of microorganisms for delivery to the intestinal tract by cellulose sulphate encapsulation. Microbial Cell Factories. 19(1). 216–216. 31 indexed citations
13.
Muendlein, Axel, Andreas Leiherer, Christoph H. Saely, et al.. (2019). Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiography. SHILAP Revista de lepidopterología. 25. 104109–104109. 3 indexed citations
14.
Muendlein, Axel, Andreas Leiherer, Eva Maria Brandtner, et al.. (2019). Real-time PCR based detection of the lactase non-persistence associated genetic variant LCT-13910C>T directly from whole blood. Molecular Biology Reports. 46(2). 2379–2385. 4 indexed citations
15.
Muendlein, Axel, Andreas Leiherer, Christoph H. Saely, et al.. (2019). The novel adipokine CTRP1 is significantly associated with the incidence of major adverse cardiovascular events. Atherosclerosis. 286. 1–6. 29 indexed citations
16.
Leiherer, Andreas, Axel Muendlein, Christoph H. Saely, et al.. (2017). The value of uromodulin as a new serum marker to predict decline in renal function. Journal of Hypertension. 36(1). 110–118. 50 indexed citations
17.
Leiherer, Andreas, Axel Muendlein, Christoph H. Saely, et al.. (2017). Serum uromodulin is associated with impaired glucose metabolism. Medicine. 96(5). e5798–e5798. 31 indexed citations
18.
Leiherer, Andreas, Axel Muendlein, Christoph H. Saely, et al.. (2016). Serum uromodulin is a predictive biomarker for cardiovascular events and overall mortality in coronary patients. International Journal of Cardiology. 231. 6–12. 38 indexed citations
19.
Brandtner, Eva Maria, et al.. (2010). A novel cell encapsulation mode for delivery of therapeutic antibodies against West Nile Virus infections that maintains steady plasma antibody levels throughout therapy. International Journal of Infectious Diseases. 14. e48–e48. 1 indexed citations
20.
Brandtner, Eva Maria. (2002). MOLECULAR IDENTIFICATION OF PpHDAC1, THE FIRST HISTONE DEACETYLASE FROM THE SLIME MOLD PHYSARUM POLYCEPHALUM. Cell Biology International. 26(9). 783–789. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guiping Li Breakdown of academic impact, for papers by Camilla Fanelli Breakdown of academic impact, for papers by Victoria Bocanegra Breakdown of academic impact, for papers by Jia‐Feng Chang Breakdown of academic impact, for papers by Mohamed M. S. Gaballa Breakdown of academic impact, for papers by Francesca Leone Breakdown of academic impact, for papers by Xiaozhen Tan Breakdown of academic impact, for papers by Bing Du Breakdown of academic impact, for papers by Curtis Noordhof Breakdown of academic impact, for papers by Abdel R.A. Hamad
Rankless by CCL
2026